Recommandé
Contenu connexe
Similaire à GLP.pptx
Similaire à GLP.pptx (20)
Dernier
Dernier (20)
GLP.pptx
- 1. Overview of GLP Regulations DR SHAZIA DAWOOD
- 2. The Birth Of GLP -In the early 1970s, the FDA investigated a number of cases of poor practice in toxicology laboratories throughout the USA - Results of this investigation in about 40 laboratories revealed many cases of poorly managed studies, insufficient training of personnel, and some cases of deliberate fraud - In 1976, the FDA published a draft regulation on GLP - After the consultation period, the final regulation was published in 1978 - This came into force in 1979 - Many countries introduced their own GLP Regulations - The OECD produced GLP Principles in 1981. These regulations have now become the international standard in the domain
- 3. What is GLP? Defined in the OECD Principles as: “...a quality system concerned with the organizational process and the conditions under which non- clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported.”
- 4. GLP Aims 1 To make incidence of False Negatives more obvious (False negative : Results demonstrate non-toxicity of a toxic substance) 2 To make incidence of False Positives more obvious (False positive : Results demonstrate toxicity of a non-toxic substance) 3 To promote mutual recognition of study data across international frontiers
- 5. Main / fundamental Points in GLP considerations Resources • Organization, personnel, facilities - building and equipment Rules • Protocols / Study plan, SOPs • concept of the Study Director as the pivotal point of study control Characterization • Test items & test systems Documentation • Raw data, final report, archives. Quality assurance • Independence from study conduct
- 6. RESOURCES Buildings: Adequate Separations Physical separations: Rooms Cabinets / Isolators Air systems and filters Separation by work areas Defined work areas One-way systems Different activities in same areas at different times Cleaning between activities Separate staff GLP WHO Training manual
- 7. Characterization Test Item GMP is not required for manufacture of GLP batches Regulatory Authorities require testing to ensure test items suitability for preclinical studies Use single lot throughout study if possible Protect test item from cross contamination/pollution Ensure traceable records for test items What are Test Systems ? Animals Bacterial Cells Organs Plants can also be Analytical equipment
- 8. Rules The protocol (or study plan) which describes how the study is designed and how it is to be conducted, including the expected timeframe of the study Approval of the Protocol (study director) Distribution of the Protocol Protocol Amendments The standard operating procedures (SOP) which provide detailed instructions about how to actually perform each technical procedure, and how to ensure sound organization of the study, its environment and data
- 9. Documentation: Results Records and recording - The raw data should include: “WHAT was done” “HOW it was done” “WHEN the work was performed” “WHO performed the work” FINAL REPORT (study director) Accurate Reporting and Deviations Statement of compliance to GLP standards and validity of data What is Archived? • Study data • Personnel data • Systems data • Quality assurance files
- 10. Quality Assurance In summary, the fundamental mission of QA is that of an independent witness to the whole preclinical research process and its organizational framework To respect GLP Principles, QA must review all phases of preclinical research - from planning to reporting and archiving of the documentation To be effective, QA must have access to staff documents and procedures at all levels of the organization, and be supported by a motivated top management the signed QA statement becomes a “release” document (not a GLP compliance statement)